echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Shadow - low white and m3

    Shadow - low white and m3

    • Last Update: 2022-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Preamble

    Acute promyelocytic leukemia with PML-RARA corresponds to AML-M3
    in FAB typing.
    It accounts for 5% to 8% of AML, and is more common in middle-aged adults, often with disseminated intravascular coagulation (DIC).

    Typical APL (coarse-granular) leukocytes are often not elevated or decreased, and fine-granular leukocyte counts are often high
    .

    Case history

    01 Case 1

    The patient is a middle-aged man presenting to the Department of
    Cardiology with arrhythmias.
    Blood routine shows that the number of white blood cells is significantly reduced, the proportion of neutrophils is reduced, and the proportion of lymphocytes is relatively increased.
    Macrocytic anemia, with different
    red blood cell sizes.

    Because the number of white blood cells is too small, the scatter plot does not show obvious abnormalities
    .

    Push the film for reexamination, a type of cells can be seen under the microscope: large cell body, butterfly shape visible nucleus, fine chromatin, more cell quality, increased granules, visible internal and external plasma, and some cells can see Auer bodies
    .

    Query the Lis system, coagulation experiments showed that D-dimer increased
    .

    Combined with blood routine, blood coagulation results and re-examination microscopic findings, a reminder report
    is issued.

    Sent for bone marrow, hyperplasia is extremely active, and a large number of abnormal cells
    can be seen.
    Such cells are large and have more particles, and "bundle-like" Auer bodies are easy to see
    .
    Typical bone marrow image of
    acute promyelocytic leukemia.

    Morphologic considerations are acute promyelocytic leukemia
    .

    Flow cytometry is consistent with acute promyelocytic leukemia immunophenotype
    .

    Biopsy combined with immunohistochemistry, consistent with acute myeloid leukemia (predisposition to APL).

    The karyotyping of chromosomes was 46,XY,t(15;17)(q24; q21)

    02 Case 2

    The patient is an older man presenting with leukopenia
    .
    CBC suggests marked leukocytes and other normal
    .

    There are no obvious anomalies
    in the scatterplot.

    Coagulation tests show a decrease in fibrinogen and an increase in
    D-dimer.

    Push re-examination, no abnormal cells
    were seen.
    Patients with isolated leukopenia, no other obvious relevant history and signs, and abnormal coagulation should be considered for further re-microscopy
    .
    Do centrifugal smear, a small number of abnormal cells can be seen: the cell body is large, the nucleus can be seen butterfly-shaped, the cell mass is large, the internal and external plasma is visible, the granules are increased, and some cells can be seen Auer bodies
    .

    Bone marrow was sent for examination, and 12% of abnormal cells
    were visible.
    Such cells: large cell body, irregular nucleus, fine chromatin, cell mass, increased particles, some cells can be seen "wood bundle" Auer bodies
    .
    Consider acute promyelocytic leukemia, which is later confirmed by genetic and chromosomal examination as APL
    .

    Case studies

    The first symptoms of both cases of APL were leukopenia, and doubts were found, and the examination was perfected, and the final diagnosis was confirmed
    .
    There are two difficulties in the re-examination of leukopenia in blood routine
    .

    First, the scatter plot is extremely difficult to
    display.
    The number of white blood cells is small, the scatter points shown in the figure are few, and when there are fewer abnormal cells, it cannot be prompted
    in time.

    The solution is to use the "low-value white blood cell" mode during retesting, increasing the volume of blood injected, and doubling the number of white blood cells passing through the channel
    .
    Scattering increases, and the detection of abnormal white blood cells reaches the level
    of normal white blood cell detection.

    Second, it is difficult to find abnormal cells by
    push-film microscopic examination.
    The number of white blood cells is small, the number of cells in the whole blood film is limited, and sometimes the complete film can not count less than 200 cells, and the target cells
    cannot be found.
    The distance between white blood cells increases with each other, low-magnification lenses are afraid of missed detection, and oil microscopes take too much
    time.

    The solution is to centrifuge and push the slide microscopy
    .
    There are two ways to do this:

    1.
    EDTA anticoagulant whole blood 2200 centrifugation for 10 minutes, discard plasma, aspirate leukocyte layer push, and stain microscopy
    .

    2.
    Wait for the blood sample to sink naturally, aspirate the plasma, centrifuge, discard the supernatant, mix well and push the tablet
    .

    After centrifugation, the detection rate of abnormal cells was greatly improved
    .

    Case summary

    Hematologic diseases with markedly elevated white blood cells are not easy to miss due
    to the large number of cells, scatter plots, and microscopic findings.
    The blood routine of leukopenia is normal due to the small amount of cells, and the scatter plot is often normal, which is relatively easy to miss
    .
    Of particular concern is promyelocytic leukemia
    with leukopenia.
    Early detection and diagnosis may be curative, but when the clinical presentation is typical, it can be life-threatening
    .
    Master the re-examination technology of leukopenia, do not easily let go of a specimen, and protect the life and health
    of patients to the greatest extent.

    【References】

    [1] Clinical Hematology Testing/Xu Wenrong Wang Jianzhong, ed.
    5th ed.
    Beijing: People's Medical Publishing House, 2012

    [2] Clinical Laboratory Diagnostic Atlas/edited by Wang Jianzhong.
    Beijing: People's Medical Publishing House, 2012

    [3] Criteria for diagnosis and efficacy of blood diseases/Shen Ti Zhao Yongqiang, editor.
    4th ed.
    Beijing: People's Medical Publishing House, 2018

    [4] Hematology/Zhang Zhinan, Hao Yushu, editor-in-chief.
    2nd ed.
    Beijing: People's Medical Publishing House, 2011

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.